Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857605PMC
http://dx.doi.org/10.1001/jama.2022.19691DOI Listing

Publication Analysis

Top Keywords

manufacturer revenue
4
revenue inhalers
4
inhalers expiration
4
expiration primary
4
primary patents
4
patents 2000-2021
4
manufacturer
1
inhalers
1
expiration
1
primary
1

Similar Publications

This study investigates the behavioral choices of manufacturers, recyclers, and customers in Trade-In Programs designed to promote recycling and environmental sustainability. Using a manufacturer-led evolutionary game model, the research explores how factors such as government policies, market demand, financial incentives, and the simplicity of participation impact stakeholder engagement in these programs. Numerical simulations were conducted to analyze the effects of specific parameters on each participants' willingness to participate.

View Article and Find Full Text PDF

A Systematic Review of Challenges and Opportunities in the Implementation of Managed Entry Agreements for Advanced Therapy Medicinal Products.

Clin Ther

December 2024

Department of Epidemiology & Health Economics, Julius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht, The Netherlands. Electronic address:

Purpose: Managed Entry Agreements (MEAs) are agreements between firms and competent authorities for pricing and reimbursement, designed to enable coverage of new medicines while managing uncertainties around their financial impact or performance. Although these agreements can facilitate patient access, their complexity and costs seem to dampen enthusiasm for implementation. Nevertheless, MEAs remain a potential route, particularly for high-cost drugs with uncertain value claims.

View Article and Find Full Text PDF

This research explores the strategic incentives driving the integration of energy economics into Bangladesh's evolving garment sector. The garments industry is a significant revenue generator for the nation; it is currently entering its prime phase, where the balance between economic growth and sustainability becomes critical. This paper presents a landscape by evaluating trends, framework conditions, and scenario-based case studies.

View Article and Find Full Text PDF

Purchasing or leasing? Equipment upgrades for a capital-constrained manufacturer.

J Environ Manage

January 2025

School of Management, University of Science and Technology of China, 96 Jinzhai Road, Hefei, Anhui, 230026, PR China. Electronic address:

Purchasing and leasing are two main methods to implement equipment upgrades, which can reduce production costs and facilitate manufacturing transformation. In practice, small and medium-sized manufacturers have insufficient cash to balance equipment upgrades and daily production. Under a two-stage setting, this study examines a pull supply chain consisting of a capital-constrained manufacturer and a retailer, where the manufacturer can borrow bank loans.

View Article and Find Full Text PDF

Biosimilars and generics have led to reduced cancer drug prices. The effect of biosimilar or generic drug competition on drug manufacturer revenue has not been previously described. In this study, the majority of top selling cancer drugs had a greater than 50 % decline in sales revenue within 2 years of generic or biosimilar market entry, reflecting both the decline in market share and reduction in unit drug price.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!